Dr Clifford Vernor Dunn Iii, MD | |
851 Marshall Phelps Rd, Windsor, CT 06095 | |
(860) 683-0756 | |
(860) 683-1555 |
Full Name | Dr Clifford Vernor Dunn Iii |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 20 Years |
Location | 851 Marshall Phelps Rd, Windsor, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548468036 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 6626822-1205 (Utah) | Secondary |
207Q00000X | Family Medicine | 62665 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Phoebe Putney Memorial Hospital | Albany, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Phoebe Physician Group Inc | 8426112350 | 342 |
News Archive
In an online-only, open access special issue of the American Journal of Public Health, researchers investigate issues of health equity, quality and disparities within the Veterans Affairs health care system.
Fallout over Virginia Gov. Bob McDonnell's decision to pull support for a controversial ultrasound abortion bill continues as a similar piece of legislation, which would require a less-invasive ultrasound, winds through that state's legislature.
Cianna Medical, Inc., the world leader in wire-free breast localization, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to extend the indication of its SCOUT reflector for use in localization of soft tissue.
Bright Note Technology™, which instantly populates all critical data on a patient chart, is now available across the entire spectrum of McKesson's ambulatory electronic health record (EHR) solutions for physician practices. This dynamic processing technology enables physicians and other providers to use their preferred charting style to capture data in a single screen note and, with one touch, synchronize searchable data across a complete chart.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
› Verified 1 days ago
Entity Name | Phoebe Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
In an online-only, open access special issue of the American Journal of Public Health, researchers investigate issues of health equity, quality and disparities within the Veterans Affairs health care system.
Fallout over Virginia Gov. Bob McDonnell's decision to pull support for a controversial ultrasound abortion bill continues as a similar piece of legislation, which would require a less-invasive ultrasound, winds through that state's legislature.
Cianna Medical, Inc., the world leader in wire-free breast localization, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to extend the indication of its SCOUT reflector for use in localization of soft tissue.
Bright Note Technology™, which instantly populates all critical data on a patient chart, is now available across the entire spectrum of McKesson's ambulatory electronic health record (EHR) solutions for physician practices. This dynamic processing technology enables physicians and other providers to use their preferred charting style to capture data in a single screen note and, with one touch, synchronize searchable data across a complete chart.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Clifford Vernor Dunn Iii, MD 851 Marshall Phelps Rd, Windsor, CT 06095-2100 Ph: (860) 683-0756 | Dr Clifford Vernor Dunn Iii, MD 851 Marshall Phelps Rd, Windsor, CT 06095 Ph: (860) 683-0756 |
News Archive
In an online-only, open access special issue of the American Journal of Public Health, researchers investigate issues of health equity, quality and disparities within the Veterans Affairs health care system.
Fallout over Virginia Gov. Bob McDonnell's decision to pull support for a controversial ultrasound abortion bill continues as a similar piece of legislation, which would require a less-invasive ultrasound, winds through that state's legislature.
Cianna Medical, Inc., the world leader in wire-free breast localization, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to extend the indication of its SCOUT reflector for use in localization of soft tissue.
Bright Note Technology™, which instantly populates all critical data on a patient chart, is now available across the entire spectrum of McKesson's ambulatory electronic health record (EHR) solutions for physician practices. This dynamic processing technology enables physicians and other providers to use their preferred charting style to capture data in a single screen note and, with one touch, synchronize searchable data across a complete chart.
The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
› Verified 1 days ago
Dr. Kevin Joseph Flanagan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 851 Marshall Phelps Rd, Windsor, CT 06095 Phone: 860-683-0756 Fax: 860-683-1555 | |
Dr. Kathleen Nugent Mueller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Bloomfield Ave, Holistic Health Partnering, Windsor, CT 06095 Phone: 860-683-0068 Fax: 860-683-1883 | |
Alison Carini, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1060 Day Hill Rd Ste 203, Windsor, CT 06095 Phone: 860-696-2450 Fax: 860-696-2460 | |
Neena K Pursnani, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 Marshall Phelps Rd, Healthone Windsor Family Medicine, Windsor, CT 06095 Phone: 860-683-0756 Fax: 860-683-1555 | |
Dr. Mahammed Parvez Saiyed, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 74 Mack St, Windsor, CT 06095 Phone: 860-298-8830 Fax: 860-298-9929 | |
Kimberly Christine Gygi, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 Marshall Phelps Rd, Windsor, CT 06095 Phone: 860-683-0756 | |
Charlene C Li, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 851 Marshall Phelps Road, Windsor Family Medicine, Windsor, CT 06095 Phone: 860-683-0756 Fax: 860-683-1555 |